Eur Rev Med Pharmacol Sci 2024; 28 (14): 3972-3972
DOI: 10.26355/eurrev_202407_36586

F. Aşır, Ç. Özgökce

Department of Histology and Embryology, Medical Faculty, Dicle University, Diyarbakır, Turkey

Eur Rev Med Pharmacol Sci 2023; 27 (6): 2182-2188–DOI: 10.26355/eurrev_202303_31751–PMID: 37013735, published on March 30, 2023.

After publication, the authors have contacted the journal to correct and update information contained in the Acknowledgments section.

Therefore, the Acknowledgments are corrected as follows:

• This study was supervised by Prof. Dr. Engin Deveci. He has agreed and accepted the final version of the published article.

All authors, including Prof. Dr. Engin Deveci, have agreed to this change and provided a confirmation letter signed by all parties.

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

F. Aşır, Ç. Özgökce
Author Correction: Momordica charantia reduced ovarian ischemia – reperfusion injury by suppressing APAF-1 expression

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 14
Pages: 3972-3972
DOI: 10.26355/eurrev_202407_36586

Tag: Erratum